|
|
|
Insider
Information: |
Clancy Paul J |
Relationship: |
Director |
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
138,295 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$20,757,220 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
138,295 |
|
|
Total
Value |
$20,757,220 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biogen Idec Inc |
BIIB |
Executive VP and CFO |
2017-04-25 |
10,813 |
|
0 |
Premium* |
|
Alexion Pharmaceuticals Inc |
ALXN |
EVP, Chief Financial O... |
2019-07-11 |
90,447 |
2017-07-10 |
0 |
Premium* |
|
Incyte Corp |
INCY |
Director |
2024-03-28 |
15,785 |
2019-03-29 |
0 |
Premium* |
|
Agios Pharmaceuticals Inc |
AGIO |
Director |
2022-05-20 |
6,549 |
2019-05-31 |
0 |
Premium* |
|
Exact Sciences Corp |
EXAS |
Director |
2023-06-08 |
14,701 |
2021-03-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
119 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 5 of 5
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2017-03-13 |
4 |
AS |
$291.55 |
$2,883,721 |
D/D |
(9,891) |
20,705 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2017-04-25 |
4 |
AS |
$290.00 |
$2,868,680 |
D/D |
(9,892) |
10,813 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2010-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
9,970 |
51,107 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2009-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
10,070 |
47,141 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2013-04-30 |
4 |
AS |
$222.57 |
$3,255,092 |
D/D |
(14,489) |
7,087 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2011-04-28 |
4 |
OE |
$37.45 |
$608,119 |
D/D |
14,766 |
51,958 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
CFO |
|
2008-02-12 |
4/A |
A |
$0.00 |
$0 |
D/D |
15,690 |
46,821 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
CFO |
|
2008-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
15,690 |
45,863 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2011-04-28 |
4 |
AS |
$98.75 |
$1,950,088 |
D/D |
(19,716) |
42,247 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2012-02-01 |
4 |
OE |
$43.50 |
$1,133,088 |
D/D |
21,400 |
42,568 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2012-02-01 |
4 |
AS |
$120.00 |
$2,568,000 |
D/D |
(21,400) |
21,168 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2011-03-05 |
4 |
D |
$71.15 |
$1,841,931 |
D/D |
(25,888) |
47,197 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2013-09-18 |
4 |
OE |
$49.65 |
$1,329,875 |
D/D |
26,785 |
33,872 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2013-09-18 |
4 |
AS |
$245.00 |
$6,562,325 |
D/D |
(26,785) |
7,087 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2011-03-05 |
4 |
OE |
$58.99 |
$1,695,963 |
D/D |
28,750 |
73,085 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Financial Officer |
|
2017-07-10 |
4 |
A |
$0.00 |
$0 |
D/D |
46,865 |
46,865 |
0 |
- |
|
ALXN |
Alexion Pharmaceuticals I... |
EVP, Chief Financial Officer |
|
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
48,228 |
95,093 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2013-09-16 |
4 |
OE |
$41.03 |
$5,556,895 |
D/D |
99,030 |
51,027 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Executive VP and CFO |
|
2013-09-16 |
4 |
AS |
$236.94 |
$23,596,311 |
D/D |
(99,030) |
7,087 |
0 |
- |
|
119 Records found
|
|
Page 5 of 5 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|